Tammy is the Senior Director of Clinical Innovation at Janssen. She is a pharmaceutical executive with more than 20 years of experience, and her expertise includes strategic and operational delivery across clinical development, regulatory affairs, and healthcare innovation. She has a passion for leading large, global teams and skilled at developing others.
She currently leads the creation and scaling of new operational approaches and technologies into clinical research with the goals of expediting drug development, reducing overall costs, and improving patient and site experiences.
Through the design and conduct of novel trial models and demonstration projects, Tammy is responsible for the overall performance & portfolio optimization of Janssen Clinical Innovation, generating data and knowledge about the feasibility, impact, and value of new capabilities.
Tammy previously served as Head of Central Clinical Planning & Solutions at Bristol Myers Squibb where she led a global team that expedited clinical trials through application of external insights, analytics and digital technology resulting in best-practice clinical trial experiences for patients, care partners, and sites. She launched her career at the organization, holding various positions in clinical development including Group Director of Global Regulatory Documentation to oversee regulatory documentation and submission strategy for oncology and immunology therapeutic areas.
Tammy holds a Bachelor of Science degree from Bucknell University in Biochemistry and her Master of Science in Clinical Pharmacology from Thomas Jefferson University.